10x Genomics is trading 6.23% down at $72.22 now on October 22, 2026, amid a broad risk-off session.
- Reuters reported renewed pressure on growth stocks as oil climbed and technology-spending concerns weighed on market sentiment.
- No October 22 company-specific announcement surfaced in the company’s listed news; its latest listed release was October 13.